Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate

Vaccine

Volumn 19, Issue 25-26, 2001, Pages 3360-3368

  Shen, Xuzhuang ^a   Lagergård, Teresa ^a   Yang, Yonghong ^b   Lindblad, Marianne ^a   Fredriksson, Margareta ^a   Wallerström, Gun ^a   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

GBS CPS III rCTB conjugate; Group B Streptococcus; Pre existing immunity

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN SUBCLASS; POLYSACCHARIDE; STREPTOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONJUGATE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA TOXIN; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; LUNG; MICE; MICE, INBRED C57BL; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; VACCINES, CONJUGATE; VACCINES, SYNTHETIC; VAGINA;

EID: 0035858099     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00532-6     Document Type: Article

References (29)

1. Group B Streptococcus
2. Epidemiology of Group B streptococcal disease in the United States: Shifting paradigms
3. Prevention of group B streptococcal infection in neonates
4. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes
5. Immune response to type III group B Streptococcal polysaccharide-tetanus toxoidconjugate vaccine
6. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib
7. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine
8. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R
9. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice
10. Preparation and preclinical evaluation of experimental Group B Streptococcus type III polysaccharide-Cholera toxin B subunit conjugate vaccine for intranasal immunization
11. Combined systemic and mucosal immunity to group B Streptococcus type III capsular polysaccharide conjugate to cholera toxin B subunit after vaccination by different mucosal routes
12. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugates prepared with different methods for intranasal immunization
13. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta
14. Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy
15. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
16. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components
17. Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate
18. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccine
19. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
20. An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides
21. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus Group C meningococcal polysaccharide-protein conjugate vaccine
22. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: A randomized controlled trial
23. Unresponsiveness following immunization with the T-cell-independent antigen dextran B512: Can it be abrogated?
24. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine
25. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines
26. Immune response to revaccination with meningococcal A and C polysacchrides in Gambian children following repeated immunization during early childhood
27. Elderly immune response to a TI-2 antigen: Heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide
28. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccine and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies
29. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity